parkinson's and glp 1 GLP-1 Drugs Disease: New Clues in Neurodegeneration GLP-1 Agonists: A New Frontier

As such, GLP-1 has been studied as a potential therapeutic for the treatment and management of high-impact neurodegenerative disorders, namely Alzheimers disease (AD) and Parkinsons disease (PD)

Schalper KA, Rodriguez-Ruiz ME, Diez-Valle R, Lpez-Janeiro A, Porciuncula A, Idoate MA, et al

GHK-Cu works through copper delivery to metalloenzymes and broad gene expression modulation, affecting not only collagen synthesis but also collagen cross-linking (via lysyl oxidase), glycosaminoglycan production, anti-inflammatory pathways, and antioxidant defense systems

Besides removing free radicals, glutathione plays a role in making DNA, forming sperm cells, and removing toxic mercury from the brain